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Abstract 
Background: Schizophrenia is associated with lower intelligence and poor educational performance 
relative to the general population. This is, to a lesser degree, also found in first-degree relatives of 
schizophrenia patients. It is unclear whether bipolar disorder I (BD-I) patients and their relatives have 
similar lower intellectual and educational performance as that observed in schizophrenia.  
Methods: This cross-sectional study investigated intelligence and educational performance in two 
outpatient samples (494 BD-I patients, 955 schizophrenia patients), 2,235 relatives of BD-I and 
schizophrenia patients, 1,104 healthy controls and 100 control siblings. Mixed-effects- and regression 
models were used to compare groups on intelligence and educational performance.  
Results: BD-I patients were more likely to have completed the highest level of education (OR=1.88 [1.66-
2.70]) despite having a lower IQ compared with controls (β=-9.09, SE=1.27, p<0.001). In contrast, 
schizophrenia patients showed both a lower IQ (β=-15.33, SE=0.86, p<0.001) and lower educational levels 
compared with controls. Siblings of both patient groups had significantly lower IQ than control siblings, 
but did not differ on educational performance. IQ scores did not differ between BD-I parents and 
schizophrenia parents, but BD-I parents had completed higher educational levels.  
Conclusions: Although BD-I patients had a lower IQ than controls, they were more likely to have completed 
the highest level of education. This contrasts with schizophrenia patients, who showed both intellectual 
and educational deficits compared to healthy controls. Since relatives of BD-I patients did not 
demonstrate superior educational performance, our data suggest that high educational performance may 
be a distinctive feature of bipolar disorder patients.  
 
Keywords: Intelligence, IQ, educational performance, cognition, familial vulnerability, bipolar disorder, 
schizophrenia 
 
1. Introduction 
Cognitive deficits are a core feature of schizophrenia (Elvevag and Goldberg, 2000; MacCabe, 2008; Kahn 
and Keefe, 2013). Lower intelligence is already present before illness manifestation (Woodberry et al.  
2008; Dickson et al.  2012) and poor scholastic achievement is associated with an increased risk for 
developing schizophrenia (van Oel et al.  2002; MacCabe et al.  2008). Several studies report that clinically 
unaffected first-degree relatives of schizophrenia patients also show lower Intelligence Quotient (IQ) and 
worse educational performance than healthy controls (Kremen et al.  1998; Cannon et al.  2000; Hughes 
et al.  2005; McIntosh et al.  2005), implying that an increased familial vulnerability to schizophrenia is 
associated with intellectual deficits. 
Whether intellectual deficits also occur in euthymic bipolar disorder (BD) patients is unclear. Although 
deficits in specific cognitive domains, e.g. executive function, attention and verbal memory, are frequently 
reported (Martinez-Aran et al.  2004; Robinson et al.  2006; Torres et al.  2007), results on global 
intelligence in BD patients (both from individual studies and meta-analyses) are equivocal (McClellan et 
al.  2004; Pirkola et al.  2005; Frangou et al.  2005; McIntosh et al.  2005; Toulopoulou et al.  2006; Robinson 
et al.  2006; Frantom et al.  2008; Bora et al.  2009; Reichenberg et al.  2009; Eric et al.  2013). These 
inconsistent findings are possibly the result of methodological deficiencies: although there have been 
large register-based studies on the association between premorbid IQ and BD, studies that focused on IQ 
in BD patients have been small (n<90) (McIntosh et al.  2005; Toulopoulou et al.  2006), consisted of 
heterogeneous samples (Robinson et al.  2006) and in some cases lacked a control group (McClellan et al.  
2004; Reichenberg et al.  2009). 
What is known is that, in contrast to findings in schizophrenia, intellectual deficits do not appear to be 
present before onset of BD (Reichenberg et al.  2002; Zammit et al.  2004); and intelligence in first-degree 
relatives of BD patients appears to be preserved (Balanza-Martinez et al.  2008). In fact, recent studies 
suggest that high premorbid intelligence (Gale et al.  2013) and excellent scholastic performances 
(MacCabe et al.  2010) are associated with an increased risk of developing BD. However, since intelligence 
after disease onset has not been examined in these studies, the question remains whether BD patients 
also had a higher IQ.   
Given the strong genetic influence in schizophrenia (Schizophrenia Psychiatric Genome-Wide Association 
Study (GWAS) Consortium, 2011) and BD (Psychiatric GWAS Consortium Bipolar Disorder Working Group, 
2011) and some degree of genetic overlap between them (International Schizophrenia Consortium et 
al.  2009), it is of interest to investigate the contribution of a familial vulnerability to differences in 
intelligence and educational performance. Additionally, delineating intelligence and educational 
performance is important, since other factors besides intelligence are predictive of educational 
performance (Chamorro-Premuzic and Furnham, 2003; Deary et al.  2007).  
We investigate IQ after onset of disease and educational performance in schizophrenia and BD patients 
and healthy controls. We include parents and siblings of these patient groups and siblings of controls to 
investigate IQ and educational performance and the association of a familial vulnerability with the 
disorders. 
 
2. Methods 
2.1 Study design 
Data were collected by three Dutch studies: Bipolar Genetics (BiG), Dutch Genetic Risk and Outcome in 
Psychosis (GROUP) and CannabisQuest. All studies were approved by the medical ethical committee and 
all participants gave written informed consent. 
BiG is an ongoing case-control study that started in June 2011 and is part of a collaboration between the 
University of California Los Angeles and the Dutch health care institutes University Medical Center Utrecht 
(UMC Utrecht), GGZ Altrecht, GGz InGeest, University Medical Center Groningen, Delta Center for Mental 
Health Care, Dimence, Parnassia (PsyQ) and Reinier van Arkel Group. BiG investigates genetic and 
phenotypic information of patients with bipolar disorder type I (BD-I), first-degree relatives and controls. 
Patients were recruited via clinicians, the Dutch patient association, pharmacies and advertisements. 
First-degree relatives were invited through the patients who participated. Controls were recruited via 
advertisements and among individuals who previously participated in scientific studies and agreed to be 
contacted for new research. Inclusion criteria for all participants were 1. Age 18 years or older 2. At least 
three Dutch-born grandparents 3. A good understanding of Dutch language. Patients with a somatic illness 
that could have influenced the diagnosis of BD were excluded. Participants were considered euthymic 
when they did not meet DSM-IV criteria for a mood episode in the last month according to the Structured 
Clinical Interview for DSM-IV (SCID-I).     
The GROUP study is an ongoing longitudinal study that investigates gene-environment interaction and 
resilience in schizophrenia spectrum disorder (SCZ) patients, first-degree relatives, controls and siblings 
of controls (Korver et al.  2012). The GROUP study is conducted by four Dutch university departments of 
psychiatry (Amsterdam, Groningen, Maastricht and Utrecht). Patients were included when they were 
between 16 and 50 years of age, had a diagnosis of a non-affective psychotic disorder according to the 
DSM-IV and a good comment of Dutch language. First-degree relatives were invited through the patients. 
The CannabisQuest study is a cross-sectional study that included adolescents and young adults from the 
general population (Schubart et al.  2011; Vinkers et al.  2013). Participants filled out an online 
questionnaire and were subsequently assessed by a psychiatric interview and neuropsychological tests at 
the UMC Utrecht. 
 
2.1.1 Participants  
For the current study, we included BD-I patients and first-degree relatives of BD-I patients (participants of 
BiG), SCZ patients and first-degree relatives of SCZ patients (participants of GROUP) and unrelated 
community controls. Controls were included from all three studies (BiG, GROUP, CannabisQuest), siblings 
of controls were included by the GROUP study only.  Participants were older than 15 years of age. The 
three studies used identical neuropsychological tests and educational assessment. All psychiatric and 
neuropsychological assessments occurred at the UMC Utrecht or one of their academic collaborative 
institutes. To avoid inclusion of an unrepresentative population, we did not exclude controls with a 
psychiatric diagnosis other than a psychotic disorder or BD. Controls and their siblings with a diagnosis of 
BD or a psychotic disorder or with a first-degree relative with BD or a psychotic disorder were excluded. 
After excluding participants who did not meet the inclusion criteria, data were available for 494 BD-I 
patients, 955 SCZ patients, 135 parents of BD-I patients (BD-I parents), 897 parents of SCZ patients (SCZ 
parents), 161 siblings of BD-I patients (BD-I siblings), 1,042 siblings of SCZ patients (SCZ siblings), 1,104 
controls and 100 siblings of controls (control siblings). Table 1 shows the characteristics of the participants 
included in the analyses. For an overview of the excluded participants, see Supplementary Figure 1.  
 
2.2 Diagnosis 
BD-I patients were diagnosed using the Structured Clinical Interview for DSM-IV (SCID-I) (First et al.  1997). 
Relatives of BD-I patients and controls included by the BiG study were diagnosed by the Mini-International 
Neuropsychiatric Interview (Sheehan et al.  1998). Participants included by the GROUP study were 
assessed through the Schedules for Clinical Assessment in Neuropsychiatry 2.1 (Wing et al.  1990) or the 
Comprehensive Assessment of Symptoms and History (CASH) (Andreasen et al.  1992). Controls that 
participated in the CannabisQuest study were diagnosed by the SCID-I. Disease history was considered 
positive when lifetime criteria for any psychiatric disorder were met. We obtained family history of 
psychiatric diseases through the Family Interview Genetic Studies (Maxwell, 1992). For SCZ patients, age 
at onset was a composite score of age of first psychosis, age of first psychiatric treatment, age of first use 
of antipsychotic medication and age of first problems (whatever came first) as previously used (Apeldoorn 
et al.  2014). For BD-I patients, age at onset was defined as age of first medication as reported in the Dutch 
version of the Questionnaire Bipolar Disorders (Leverich et al.  2001; Suppes et al.  2001), given the 
insidious onset of BD-I and the high probability of recall bias in the retrospective assessment of first 
reported symptoms.  When age at first reported symptoms was used in the models instead of age at first 
medication, the reported results did not change. 
 
2.3 Intelligence Quotient 
To estimate IQ we used four subtests of the Dutch version of the Wechsler Adult Intelligence Scale-III 
(WAIS-III) (Wechsler D., 1997) consisting of the subtests ‘Information’, ‘Block Design’, ‘Digit Symbol 
Coding’ and ‘Arithmetic’. This combination of subtests has been shown to most fully account for full-scale 
IQ in both schizophrenia patients (R2=0.90) and controls (R2=0.86) (Blyler et al.  2000).  
 
2.4 Educational performance 
In the Netherlands, most schools are state schools which are ordinally organized into primary, secondary 
and tertiary education tiers. From 4 until 12 years of age, all children receive primary education. After 12 
years, children are streamed into four levels of secondary education (low, intermediate, high preparatory 
vocational and pre-university), each level requiring greater intellectual and scholastic abilities (Vonk et al.  
2012). After passing the examinations in secondary education, there are three levels of tertiary education 
possible (intermediate professional education, higher professional education and university). After 
achieving a master’s degree at university, it is possible to enroll in a doctoral program. The Dutch school 
system, with different educational levels and similar quality of education across schools, allows a detailed 
insight into intellectual and scholastic ability.  
We asked participants to record their highest completed level of education. To have approximately 
equally distributed groups, we delineated six categories: Level 1: Low (no education, primary education 
and low secondary education); Level 2: Intermediate secondary education; Level 3: Intermediate 
professional education; Level 4: High preparatory vocational and pre-university; Level 5: Bachelor degree 
(Higher professional education) and Level 6: University (Master’s degree or PhD degree).  
 
2.5 Statistical analyses 
We studied the association of group status (five comparisons: 1. BD-I patients versus controls and SCZ 
patients versus controls 2. BD-I patients versus SCZ patients 3. BD-I siblings versus control siblings and SCZ 
siblings versus control siblings 4. BD-I siblings versus SCZ siblings 5. BD-I parents versus SCZ parents) with 
two outcome variables: IQ and educational performance. Since we did not include parents of controls, we 
compared BD-I parents with SCZ parents. The statistical analyses were carried out using the R package for 
statistical computing (R core team, 2014) and SPSS 20.0. Assumptions were checked before analysing 
data. Subjects with missing data were excluded listwise from the analyses. We used ANOVA and t-tests to 
compare the patient, control and parent groups for age and age at onset and χ2-tests to compare these 
groups for gender and disease history. We used mixed-effects models with ‘family’ (indicating the family 
a person belonged to, used to account for relatedness within the sibling samples) as random factor to 
compare the three sibling groups on age, gender and disease history. We checked whether selective drop-
out had occurred for missing values by comparing the participants included in the IQ analyses with the 
participants included in the analyses on educational performance. We conducted χ2-tests for gender, 
disease history and frequency of subjects within the analyses and performed t-tests for age, age at onset 
and IQ.  
 
First, we studied the association of the disorders with IQ. To investigate whether patients differed from 
controls, we used a linear mixed-effects model with two dummy variables (BD-I versus controls and SCZ 
versus controls) as main determinants and IQ as outcome. We included a random factor ‘study’ (indicating 
the study a participant belonged to) to control for bias that may occur when samples from different 
studies are compared. To investigate whether siblings of patients differed from control siblings on IQ we 
used a linear mixed-effects model with two dummy variables (BD-I siblings versus control siblings and SCZ 
siblings versus control siblings) as main determinants, IQ as outcome and ‘study’ and ‘family’ as random 
factors.  
Since the indicator ‘study’ was identical for the patient, parent and sibling groups, we were unable to use 
this indicator as random factor for comparisons between BD-I and SCZ patients and BD-I and SCZ relatives. 
Therefore, we conducted two separate linear models with IQ as outcome and patient (BD-I patients versus 
SCZ patients) and parent (BD-I parents versus SCZ parents) groups as main determinants. To compare BD-
I siblings with SCZ siblings, we conducted a linear mixed-effects model with sibling group as main 
determinant and ‘family’ as random factor.  
 
Subsequently, we studied the association of the disorders with educational performance. We applied five 
different thresholds for the six categories for level of education and compared participants that completed 
an educational level and above with the remaining group (threshold 1: completing ‘Intermediate 
secondary education’ or higher versus completing ‘Low’; threshold 2: completing ‘Intermediate 
professional education’ or higher versus below; threshold 3: completing ‘High preparatory vocational and 
pre-university’ or higher versus below; threshold 4: completing ‘Bachelor’ or higher versus below; 
threshold 5: completing ‘University’ versus below). We used logistic regression analyses with dummy 
coding for patients and controls to investigate the differences in educational performance between 
patients and controls. Furthermore, we conducted logistic regression analyses to investigate educational 
performance between patient groups and parent groups. In addition, to estimate differences between 
parents and controls in absence of a group of parents of controls, we ran 10,000 permutation tests in 
which we compared the parent groups with a random sample of 600 controls. We analysed educational 
performance of siblings with a generalized mixed model with ‘family’ as random factor. Since we used five 
thresholds as outcome variables, we corrected for multiple testing by applying a Bonferroni correction 
and considered p-values <0.01 as statistically significant. 
Additionally, to account for illness effects in siblings, we excluded 14 BD-I and 50 SCZ siblings with a 
psychotic disorder or BD and repeated the analyses of IQ and educational performance. We also repeated 
the IQ and educational performance analyses in BD-I patients, SCZ patients and controls older than 34 
years of age to rule out that age differences between these groups influence the results.  
Age and gender were covariates in all models and age at onset was a covariate in the comparison of BD-I 
patients and SCZ patients. We calculated Cook's Distances to investigate potential outliers. For two 
thresholds in the sibling comparisons (‘Intermediate secondary education’ and ‘University’) we could not 
calculate Cook’s Distance due to non-convergence of the mixed-effects model, so we calculated Cook's 
Distance without a random factor in a linear model.  
 
3. Results 
We included 4,888 participants. Data on educational performance were missing for 24 BD-I patients, 8 
SCZ patients, 5 BD-I parents, 55 SCZ parents, 6 BD-I siblings, 17 SCZ siblings and 56 controls. Listwise 
exclusion of these participants resulted in a sample of 4,717 participants included in the analyses of 
educational performance. There was no evidence of selective drop-out for missing values; the frequency 
of subjects within each group did not change (Patients and controls: χ2=0.55, p=0.76; Patients: χ2=0.27, 
p=0.60; Parents: χ2=0.04, p=0.85; Siblings and controls: χ2=0.05, p=0.98; Siblings: χ2=0.03, p=0.86) and 
there were no differences in demographic characteristics between the participants included in the IQ 
analyses and the participants included in the analyses of educational performance (Gender: χ2=0.01, 
p=0.94; Age: t=0.40, p=0.69; IQ: t=-0.60, p=0.55; Age at onset: t=0.25, p=0.80; Disease history: χ2=0.07, 
p=0.79).  
The groups differed on several demographic factors (see Table 1). Figures 1 and 2 show the distribution 
of IQ and educational performance by group.  
 
Table 1. Demographics: Participants included in IQ analyses  
 Patients 
BD-I n=494 
Parents 
BD-I n=135 
Siblings BD-I 
n=161 
Patients SCZ  
n=955 
Parents 
SCZ  
n=897 
Siblings SCZ 
n=1,042 
Controls  
n=1,104 
Control 
siblings 
n=100 
BD-I patients vs. SCZ 
patients vs. controls 
BD-I siblings vs. 
SCZ siblings vs. 
controls 
BD-I parents 
vs. 
SCZ parents 
Gender male  
n  (%)* 
217 
(43.9%) 
57 (42.2%) 49 (30.4%) 743 (77.8%) 380 
(42.4%) 
481 (46.2%) 538 
(48.7%) 
41 
(41.0%) 
BD-I= 
controls<SCZ 
BD-
I=control=SCZ 
BD-I=SCZ 
Age mean 
(SD)* 
49.3 (12.1) 65.0 (7.1) 54.4 (11.3) 27.2 (7.0) 54.8 (6.8) 28.0 (8.2) 28.9 
(12.5) 
30.3 
(11.6) 
BD-I> 
controls>SCZ 
BD-I> 
controls>SCZ  
BD-I>SCZ 
Age at onset  
mean (SD)* 
32.0 (10.5)   22.53 (6.53)     BD-I >SCZ    
Disease    
history n 
(%)*1 
 31 (23.0%) 63 (39.1%)  195 
(21.7%) 
176 (16.9%) 274 
(24.8%) 
12 
(12.0%) 
 BD-I> 
control=SCZ 
BD-I=SCZ 
IQ mean 
(SD)* 
96.8 (14.1) 102.2 
(15.1) 
106.3 (16.1) 94.9 (15.8) 102.9 
(17.0) 
102.8 (15.7) 107.8 
(15.2) 
111.2 
(15.1) 
BD-I< 
controls>SCZ  
BD-I< 
controls>SCZ 
BD-I=SCZ 
*Significant difference between groups at p<0.01 
1Lifetime psychiatric diagnosis. Controls with BD or a psychotic disorder or with first-degree relatives with BD or a psychotic disorder are not included. 
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Figure 1. Boxplots of IQ scores  
 
1a. Controls, BD-I and SCZ patients                 1b. Control siblings, BD-I siblings and SCZ siblings               1c. BD-I parents and SCZ parents 
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Figure 2. Educational performance by group  
2a. Controls, BD-I and SCZ patients            2b. Control siblings, BD-I siblings and SCZ siblings                 2c. BD-I parents and SCZ parents 
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3.2 BD-I and SCZ patients versus controls 
Both BD-I and SCZ patients had a significantly lower IQ than controls (BD-I: β=-9.09, SE=1.27, p<0.001; 
SCZ: β=-15.33 SE=0.86, p<0.001). BD-I patients had a significantly higher IQ than SCZ patients (β=4.55, 
SE=1.35, p=0.001). SCZ patients had completed lower educational levels than BD-I patients and 
controls. In contrast, BD-I patients were more likely to have completed the highest educational level 
than controls. Table 2 shows the results of the analyses of educational performance in patients and 
controls.  
 
To investigate whether the characteristics of BD-I patients with a low IQ and high educational 
performance differed from the other BD-I patients with high educational performance, we compared 
patients with an IQ below 95 (1/3 standard deviation below the average of 100) who had completed 
University (n=15) with normal IQ BD-I patients who had completed University (n=92). We found no 
differences between the groups for age (t=1.74, p=0.09), age at onset (t=0.75, p=0.46) and gender 
(χ2=2.31, p=0.13).  
 
To account for the effect of age difference between the patients and controls, we repeated the IQ and 
educational performance analyses in patients and controls older than 34 years of age. We found very 
similar results as in the main analyses; BD-I patients and SCZ patients had a lower IQ than controls (BD-
I: Beta=-8.08, SE=1.45, p<0.001; SCZ: Beta=-15.81, SE=1.66, p<0.001) and BD-I patients had a higher IQ 
than SCZ patients (Beta=5.77, SE=1.73, p=0.001). Furthermore, SCZ patients had lower educational 
performance than BD-I patients and controls, whereas BD-I patients were more likely to have 
completed University (See Supplementary table 1).   
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Table 2. The association of disorder with educational performance  
 
Threshold Highest completed 
education 
BD-I versus SCZ  
OR and 95% CI 
BD-I versus 
controls  
OR and 95% CI 
SCZ versus controls  
OR and 95% CI 
1 Intermediate 
secondary 
education 
3.34 [2.80-5.57]* 0.76 [0.64-1.24] 0.16 [0.14-0.22]* 
2 Intermediate 
professional 
education 
2.63 [2.29-3.90]* 0.70 [0.62-0.99] 0.22 [0.20-0.27]* 
3 High preparatory 
vocational and pre-
university 
2.55 [2.25-3.63]* 0.97 [0.88-1.28] 0.30 [0.28-0.36]* 
4 Bachelor 3.41 [2.98-5.03]* 1.10 [1.00-1.44] 0.38 [0.35-0.48]* 
5 University 5.78 [4.77-10.04]* 
 
1.88 [1.66-2.70]* 0.43 [0.38-0.63]* 
*Does not include unity 
 
3.3 BD-I and SCZ siblings versus control siblings 
BD-I and SCZ siblings had a similar IQ (β=3.49, SE=2.00, p=0.08), which was significantly lower than that 
of control siblings (BD-I: β=-5.77, SE=2.41, p=0.02; SCZ: β=-8.34, SE=1.68, p<0.01). Moreover, although 
Figure 2 suggests that BD-I siblings are higher educated than SCZ siblings and control siblings, the three 
sibling groups did not significantly differ in educational performance after adjusting for age and 
gender.  
Analysis of (healthy) siblings without BD-I or a psychotic disorder revealed lower intelligence for SCZ 
siblings (β=-8.20, SE=1.67, p<0.001) but not for BD-I siblings (β=-4.73, SE=2.44, p=0.05) as compared 
with controls. Instead, BD-I siblings had a higher IQ than SCZ siblings (β=4.49, SE=2.06, p=0.03). The 
results for educational performance did not change: the three sibling groups did not significantly differ 
on educational performance (see Supplementary Table 2). Table 3 shows the results of the analyses of 
educational performance in relatives of patients and controls.   
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3.4 BD-I parents versus SCZ parents 
BD-I parents had a similar IQ as SCZ parents (β=-1.22, SE=1.70, p=0.47), but were more often higher 
educated (see table 3). The results of 10,000 permutation tests revealed that BD-I parents had similar 
educational performance as random (unrelated) controls. SCZ parents had lower educational 
performance than unrelated controls (see Supplementary table 3). 
 
Table 3. The association of familial vulnerability with educational performance  
 
 
   
Siblings 
 
Parents 
Threshold Highest completed 
education 
BD-I siblings versus 
SCZ siblings 
OR and 95% CI 
BD-I sibings 
versus controls 
siblings  
OR and 95% CI 
SCZ versus 
controls  
OR and 95% CI 
BD-I parents 
versus SCZ 
parents 
OR and 95% CI 
1 Intermediate secondary 
education 
1.86 [0.79-22.21]1 0.44 [0.08-
58.89]1 
0.24 [0.05-
17.64]1 
2.00 [1.64-3.56] 
2 Intermediate 
professional education 
0.51 [0.40-1.07] 0.42 [0.31-1.03] 0.88 [0.71-1.58] 
1.48 [1.27-2.33] 
3 High preparatory 
vocational and pre-
university 
1.24 [1.02-2.17] 0.76 [0.60-1.50] 0.62 [0.53-1.00] 
1.88 [1.63-2.87]* 
4 Bachelor 0.63 [0.51-1.15] 0.87 [0.68-1.82] 1.40 [1.16-2.44] 1.83 [1.58-2.80]* 
5 University 0.43 [0.17-5.68] 0.89  [0.26-33.69] 2.03 [0.72-41.94] 0.96 [0.77-1.84] 
1Age was left out due to problems converging the models 
*Does not include unity 
 
3.5 Analysis of outliers and ethnicity 
None of the participants fulfilled the criteria for outliers by Cook’s Distance. Since not all SCZ patients, 
SCZ relatives and controls were Dutch, we analysed the data from the Caucasian participants only (SCZ 
patients: n=756; SCZ parents: n=798; SCZ siblings: n=867; controls: n=1067; control siblings: n=92). The 
results of these analyses did not differ from the results we found for the entire group of participants 
(data not shown).  
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4. Discussion 
In the largest cross-sectional study on IQ and educational performance in BD-I and SCZ patients and 
relatives to date, patients with established BD-I had a lower IQ, but superior educational performance 
relative to healthy controls. By contrast, SCZ patients had lower IQ as well as inferior educational 
performance compared to controls, suggesting that IQ in schizophrenia is affected in an earlier stage 
of the illness. The fact that educational performance of BD-I siblings and BD-I parents was comparable 
to that of controls while in patients it was higher, raises the question as to whether high educational 
performance is associated with bipolar disorder itself rather than with a familial vulnerability to 
develop the illness. 
 
Cognitive deficits in BD-I patients have been reported previously (McIntosh et al.  2005; Toulopoulou 
et al.  2006) and our findings are in line with a recent meta-analysis in 1,026 euthymic BD patients 
(Mann-Wrobel et al.  2011). Lower IQ appears to be associated with the illness itself, as healthy BD-I 
siblings do not show a significantly reduced IQ compared with control siblings. In contrast, healthy SCZ 
siblings had a lower IQ than control siblings, indicating that lower IQ may be associated with a familial 
vulnerability for SCZ. The current study emphasizes that IQ may not fully account for educational 
performance, as we show different results for both domains in BD-I patients. Moreover, our results 
confirm findings by previous register-based studies that low educational performance is associated 
with schizophrenia and high educational performance is associated with BD (MacCabe et al.  2008; 
MacCabe et al.  2010).  
 
One of the explanations for the contradictory finding regarding high educational performance and 
lower intelligence in BD-I patients is that intelligence may have been higher before onset of BD, but 
decreased after illness onset (Trotta et al.  2014) possibly as a result of number of hospitalizations 
(Robinson and Ferrier, 2006), traumatic experiences (Aas et al.  2011) or long-term medication use 
(Pachet and Wisniewski, 2003; Senturk et al.  2007; Wingo et al.  2009; Vreeker et al.  in press). 
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Additionally, prodromal symptoms like elevated energy (Egeland et al.  2000) may have contributed to 
high educational performance.  
Interestingly, BD-I siblings and BD-I parents did not have higher educational performance than 
controls, which suggests that high educational performance is associated with the illness itself, rather 
than with a familial vulnerability to BD. This is partly in line with earlier findings showing fewer 
completed years of education for non-bipolar co-twins, but not for bipolar co-twins, as compared with 
controls (Vonk et al.  2012). From an evolutionary perspective our results raise the question whether 
high (educational) achievement could be a result of an adaptive advantage of the disorder, associated 
with benefits in leadership (Akiskal and Akiskal, 2005).  
 
Limitations 
The current study has several limitations. First it should be noted that the cross-sectional design of our 
study does not allow us to conclude that there has been a decline in IQ in BD-I patients. Also, BD-I 
patients were significantly older than SCZ patients and controls which may have resulted in a greater 
opportunity for BD-I patients to attend higher education. However, analyses of patients and controls 
older than 34 years of age, yielded very similar results. Furthermore, younger people tend to be higher 
educated than older people in general (Barro and Lee, 2013) and the fact that BD-I patients were higher 
educated despite their higher age could also underscore their superior educational performance.  
Despite careful analysis that incorporate multilevel analysis, sensitivity analysis and exploration of a 
range of possible confounders, residual confounding may remain as we are unable to adjust for all 
possible factors (e.g. medication use, comorbid disorders) that could have influenced IQ scores. 
Particularly, information on parental socioeconomic status is absent and we cannot rule out the 
possibility that differences in parental socioeconomic status may have influenced our results.  
However, since tuition fees are low and income differences are substantially reduced by social security 
and taxes in the Netherlands we do not expect that differences in socioeconomic status may have 
accounted for our results on educational performance.  
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A final limitation is that, despite our large sample, we cannot be sure that our populations are 
representative; inherent to clinical cohorts is Berkson's bias (bias toward those willing to participate 
and those under treatment) (Regeer et al.  2009).  
 
Conclusions 
We show that despite BD-I patients having a lower IQ relative to controls, they are more likely to have 
completed the highest level of education. This contrasts with our findings in SCZ patients, who 
demonstrate both lower IQ and lower educational performance. The fact that BD-I patients, but not 
BD-I parents or BD-I siblings, had more often completed the highest level of education compared with 
controls suggests that high educational performance may be a distinctive feature of the illness itself.   
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Supplementary tables and figures 
Table S1. Educational performance of BD-I patients, SCZ patients and controls older than 34 years 
Threshold 
Highest completed 
Education 
BD-I patients versus 
controls 
SCZ patients versus 
controls 
BD-I patients versus 
SCZ patients 
1 
Intermediate secondary 
education 
1.36 [1.12-2.38] 0.17 [0.13-0.32]* 7.33 [5.62-15.91]* 
2 
 
Intermediate professional 
education 
1.08 [0.94-1.65] 0.25 [0.21-0.42]* 4.50 [3.68-8.12]* 
3 
 
High preparatory vocational 
and pre-university 
1.32 [1.18-1.84] 0.44 [0.38-0.67]* 3.00 [2.54-4.85]* 
4 Bachelor 1.38 [1.24-1.90] 0.48 [0.41-0.74]* 2.83 [2.40-4.56]* 
5 University 2.53 [2.17-3.96]* 0.78 [0.62-1.48] 3.77 [3.01-7.20]* 
*Does not include unity 
 
 
 
 
 
Table S2. The association of familial vulnerability with educational performance in siblings without 
BD or a psychotic illness 
 
 
Threshold Highest completed education 
BD-I siblings versus  
SCZ siblings 
OR and 95% CI 
BD-I siblings versus 
control siblings  
OR and 95% CI 
SCZ siblings versus 
control siblings  
OR and 95% CI 
1 
Intermediate secondary 
education 
1.80 [0.89-14.07]1 1.33 [0.54-17.80]1  0.60 [0.47-1.23]1  
2 
Intermediate professional 
education 
0.43 [0.32-0.94] 0.37 [0.27-0.95] 0.92 [0.75-1.70] 
3 
High preparatory vocational 
and pre-university 
1.14 [0.93-2.04] 0.72 [0.57-1.45] 0.64 [0.54-1.03] 
4 
 
Bachelor 
 
0.60 [0.48-1.10] 0.87 [0.67-1.82] 1.47 [1.21-2.55] 
5 
 
University 
 
0.47 [0.19-6.35] 1.01 [0.29-38.24] 2.11 [0.75-43.33] 
1Age was left out due to problems converging the models 
*Does not include unity 
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Table S3. Educational performance in parents compared to 600 random controls 
Threshold 
Highest completed 
education 
BD-I parents versus random 
controls 
Median OR and 95% CI 
SCZ parents versus 
random controls 
Median OR and 95% CI 
1 
Intermediate secondary 
education 
0.76 [0.57-1.78] 0.34 [0.28-0.59]* 
2 
Intermediate professional 
education 
0.54 [0.43-1.03] 0.39 [0.34-0.60]* 
3 
High preparatory vocational 
and pre-university 
0.92 [0.76-1.61] 0.48 [0.42-0.69]* 
4 Bachelor 0.82 [0.68-1.43] 0.62 [0.55-0.90] 
5 University 0.62 [0.47-1.38] 0.66 [0.55-1.12] 
*Does not include unity 
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Figure S1. Flowchart of participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bipolar Genetics:   GROUP:   CannabisQuest: 
540 BD-I patients   970 SCZ patients   483 Controls 
135 Parents of BD-I patients 897 Parents of SCZ patients 
162 Siblings of BD-I patients 1,042 Siblings of SCZ patients 
193 Controls   476 Controls 
    101 siblings of controls 
 
 
 
Excluded family members:  
- 1 BD sibling was not euthymic 
during the interview 
 
 
 
 
 
 
 
 
 
 
 
Excluded patients: 
- 2 patients had prior experience 
with the WAIS 
- 8 patients with a somatic illness 
that could have influenced the 
results 
- 36 BD-I patients that were not 
euthymic during the interview 
- 15 patients did not fulfill criteria 
for a schizophrenia spectrum 
disorder 
 
 
 
 
 
 
Excluded controls: 
-8 controls with a diagnosis of BD 
or any psychotic disorder 
- 37 controls with first-degree 
relatives with a diagnosis of BD or 
any psychotic disorder 
- 1 control experienced a 
depressive episode during the 
interview 
- 2 controls with a somatic illness 
that could have influenced the 
results 
- 1 control sibling with a diagnosis 
of a psychotic disorder 
 
 
 
 
 
Missing data on level of education: 
24 BD-I patients  5 Parents of BD-I patients 
8 SCZ patients  55 Parents of SCZ patients 
56 Controls  6 Siblings of BD-I patients 
17 Siblings of SCZ patients 
Missing data on age at onset: 
8 BD-I patients 
33 SCZ patients 
Participants included in analyses level of education: 
470 BD-I patients 
947 SCZ patients 
130 parents of BD-I patients 
842 parents of SCZ patients 
155 siblings of BD-I patients 
1,025 siblings of SCZ patients  
1,048 controls 
100 siblings of controls 
 
 
 
 
 
Participants included in analyses IQ:  
494 BD-I patients   135 parents of BD-I patients     
955 SCZ patients   897 parents of SCZ patients 
161 siblings of BD-I patients 1,042 siblings of SCZ patients 
1,104 controls   100 siblings of controls 
 
 
 
 
 
 
